CD8A and glioma: A pan-cancer study published in “Annals of oncology” reported that for cancers like glioma, where there is no correlation between CD8+ T cell levels and neoantigen loads, higher TMB is associated with tolerance to immune response and immunotherapy (McGrail et al., 2021).